ArticleBMC neurology2021

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.

Kaijia Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.